Technologyai
OpenAI Acquires Orchestra Bio to Expand Biotech AI Capabilities
OpenAI has officially announced the acquisition of startup Orchestra Bio, integrating its specialized team and technological assets into the corporate fold. This strategic purchase is aimed directly at strengthening OpenAI's life sciences initiatives, particularly the Rosalind artificial intelligence model. Alongside the model, the incoming talent will contribute to the ongoing development of the Rosalind Workbench, a comprehensive platform designed to assist researchers in orchestrating experiments and interpreting complex scientific data.